Mergers & AcquisitionsBy The Online Investor Staff, updated Thu., Mar. 4, 1:32 PM
|This Slide: #22 of 100|
Slide #22. WuXi AppTec — OXGENE
WuXi AppTec (WUXAY)
WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide.